Search

everythinglearnresearchcommunity

for

Search:↓

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Citrullus colocynthis fruit extract and its compound may help treat enlarged prostate.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

Androgen use may increase the risk of stroke, but more research is needed.

Prepubertal girls with hypertrichosis have more sensitive androgen receptors, leading to increased body hair growth.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Clascoterone 1% cream is a promising new treatment for acne.

Eating healthy, exercising, and changing behaviors are the best first steps to treat Polycystic Ovary Syndrome (PCOS).

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

The document concludes that managing PCOS involves lifestyle changes, medication for symptoms, and weight loss for fertility improvement.

Hormones cause hair loss by affecting cell growth and weakening cell attraction.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

Androgens can affect glucocorticoid signaling in specific mouse brain areas.